| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.9B | $9.1B | $7.8B | $6.7B | $6.4B | $3.4B | $3.7B | $3.3B |
| Cost of Revenue | — | $7.4B | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B |
| SG&A Expense | $0.7B | $0.7B | $0.7B | $0.6B | $0.6B | $1.1B | $1.2B | $1.1B |
| Operating Income | $1.4B | $1.2B | $0.7B | $0.4B | $0.2B | $-2.6B | $-1.1B | $-0.5B |
| Net Income | $1.0B | $0.8B | $0.1B | $-0.1B | $0.0B | $-0.0B | $-2.4B | $-2.3B |
| EPS (Basic) | $2.34 | $1.96 | $0.13 | $-0.24 | $0.03 | $-0.09 | $-5.40 | $-5.00 |
| EPS (Diluted) | $2.30 | $1.91 | $0.12 | $-0.24 | $0.03 | $-0.09 | $-5.40 | $-5.00 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.1B | $9.9B | $9.7B | $9.4B | $10.0B | $19.7B | $23.5B | $24.8B |
| Current Assets | $5.5B | $5.5B | $5.2B | $5.0B | $5.3B | $11.4B | $11.9B | $11.8B |
| Cash & Equivalents | $1.0B | $1.2B | $1.0B | $1.1B | $1.3B | $4.8B | $5.2B | $5.5B |
| Total Liabilities | $6.7B | $6.7B | $6.5B | $6.2B | $6.6B | $15.4B | $15.8B | $14.3B |
| Current Liabilities | $4.9B | $4.9B | $4.5B | $4.2B | $3.9B | $10.4B | $10.1B | $9.1B |
| Stockholders' Equity | $3.4B | $3.1B | $3.1B | $3.2B | $3.4B | $4.2B | $7.7B | $10.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.0B | $0.7B | $0.4B | $0.8B | $0.7B | $0.8B | $-0.2B |
| Investing Cash Flow | $-0.3B | $-0.1B | $-0.1B | $0.2B | $0.8B | $-0.2B | $-0.4B | $-0.5B |
| Capital Expenditures | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.5B | $0.4B |
| Financing Cash Flow | $-1.6B | $-0.6B | $-0.7B | $-0.8B | $-5.1B | $-1.1B | $-0.8B | $-0.4B |